FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10326011000001101: Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35562701000001118 Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35562801000001110 Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Is a Selegiline 1.25mg oral lyophilisates sugar free 30 tablet true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Is pack of Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has active ingredient Selegiline hydrochloride false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has AMP Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has specific active ingredient Selegiline hydrochloride true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Has dispensed dose form Conventional release oral lyophilisate true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start